Navigation Links
Reportlinker Adds Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
Date:12/8/2010

uidelines.

- Annualized Spanish prostate cancer therapeutics market revenue, annual cost of therapy and treatment usage patterns data (for hormone therapy and hormone resistant or refractory therapy) from 2001 to 2009, forecast for 11 years to 2020.

- Insightful review of the key industry drivers, restraints and challenges and predicted impact of key events.

- Competitor assessment including drug launch analysis and drug sales forecasts.

- Product profiles covering efficiency, safety, clinical study details, annual cost, regulatory approvals, LCM (Life Cycle Management) activities and drug sales forecast.

- Analysis of unmet need in the market and target product profiles including opportunity for target products.

- Technology trends analytic framework to assess the strength of the pipeline.

- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include EGFR inhibitors, VEGF inhibitors, tyrosine kinase inhibitor, angiogenesis inhibitors and others.

- An overview of the most promising drugs including clinical study details, efficacy, safety, collaboration agreements, marketing rights and launch analysis.

- Analysis of the current and future market competition in the Spanish Prostate Cancer therapeutics market. Company profiles including business description, financial overview and SWOT analysis. Key future market players covered include Sanofi-aventis, Pfizer, Inc., AstraZeneca PLC, Bristol-Myers Squibb, Medivation, Takeda Pharmaceuticals and Dendreon Corporation.

- Analysis of licensing agreements during 2004-2010 in the prostate cancer therapeutics market. Merger and Acquisition (M&A analysis) which includes M&A deals by size and geography.

- Strategic assessment of the market through market impact analysis, future market scenario and company analysis.

- Direct qu
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... N.C. , June 1, 2015  bioMérieux, a ... diagnostics, has been invited to join the White ... antibiotic use in the U.S. as a means to ... sectors, will gather tomorrow, June 2, 2015, to discuss ... five years to slow the emergence of antibiotic-resistant bacteria, ...
(Date:6/1/2015)... , June 1, 2015 The Middle Eastern ... diagnostic tool which is replacing CT because of its higher ... more popular one between the two available systems of MRI, ... in the top and bottom and do not enclose the ... There is a study which shows that one in every ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ONCOLOGY ... engaged in the development and commercialization of novel, ... it has met with the U.S. Food and ... filing of an Investigational New Drug (IND) application ... a result of the meeting, Neovia has clarified ...
Breaking Medicine Technology:bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Neovia Oncology Announces First IND Meeting 2
... 2010 Sequenom, Inc. (Nasdaq: SQNM ) ... Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized ... study is designed to evaluate the clinical performance of ... detection of an overabundance in maternal blood of chromosome ...
... 22, 2010 Renal Advantage and Liberty Dialysis, which last ... of dialysis services in the U.S., today announced that they ... were not disclosed – was completed on December 17, 2010. ... patients in 260 locations in 32 states. "The ...
Cached Medicine Technology:Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 2Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 3Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 4Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Marcy Herrmann as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in life ... for professional women, boasting more than 700,000 members and ... to present Marcy with this distinction,” said NAPW President ...
(Date:6/1/2015)... 02, 2015 The National Association ... a 2015-2016 inductee into its VIP Woman of ... prestigious distinction for leadership in business. NAPW is ... women, boasting more than 700,000 members and over ... welcome Kathy into this exceptional group of professional ...
(Date:6/1/2015)... Carson Energy also announced they have selected ... AdvantaIRA Trust, LLC is the country’s largest self-directed IRA ... positions using IRA’s does 2 things:, 1. It gives ... if there current cash position will not allow for ... Carson and their investors to be able to participate ...
(Date:6/1/2015)... LONE TREE, CO (PRWEB) June 01, 2015 ... to announce they have been named an Ultherapy® ... Ultherapy. Atagi Plastic Surgery and Skin Aesthetics is one ... by Ulthera as a premier treatment provider. , ... with Ultherapy in the Denver area has led the ...
(Date:6/1/2015)... 2015 On May 14, 2015, the ... hosted the Cherry Creek Chamber of Commerce for the ... care centers typically do not offer primary care services ... Cherry Creek Urgent Care staff to schedule family care ... 5:30 to 7:30 p.m. the center hosted presidents, CEOs, ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... who are diagnosed with prostate cancer by biopsy are more ... aggressive// case of the disease than the biopsy results would ... Medical Center researcher. ,The finding suggests that misleading ... to receive inadequate or inappropriate treatment that is not aggressive ...
... new blood thinner, one of the first signs the drug ... bleeds and bruising,// an inconvenient side effect of preventing the ... and stroke. While potentially life-saving, the drugs can also pose ... monitoring of blood levels. ,So when he didn’t ...
... disabled? Can parents arrange surgical interventions on their children, hoping life ... a raised in a beated debate in the US. ... stopped developing when she was only three months old. ... recognize her family members and to enjoy music. But she can ...
... news. His colon cancer, which was treated two years ... with chemotherapy in 2005 after doctors removed his colon in ... metastatic. Yet after recent surgery to remove a growth ... liver. ,Though patients often can be cured of ...
... pill to control high blood pressure and new drugs ... Clinic researchers have designed two promising new cardiovascular treatment ... pill form to lower high blood pressure and a ... kidney function. ,In the process, they ...
... children, yet the number of pediatric orthopedists trained to ... decreasing nationwide. The management of fractures in children is ... is needed to provide the best care for these ... for Special Surgery (HSS). ,Fractures in ...
Cached Medicine News:Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Debate in US: Who Should Decide for Disabled People? 2Health News:White House Press Secretary to Battle Second Round of Colon Cancer 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3
Idophor PVP Scrub Winged Sponges...
Triad Plus PVP-I Scrub Winged Sponges...
... preoperative skin preparation an ... site infections. Scrub Care brand ... offer high efficacy and safety ... Prevail-Fx offers the highest level ...
Single-dose applicator. Provides a superior, hands-off "friction scrub," enhancing the efficacy of the antiseptic solution it delivers....
Medicine Products: